- Investing Ideas
- Israeli Biotech Stocks
Israeli Biotech Stocks
Results
9
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
9 companies
Kamada
Market Cap: ₪1.5b
Manufactures and sells plasma-derived protein therapeutics.
KMDA
₪25.55
7D
-4.4%
1Y
0.7%
G.F.C Green Fields Capital
Market Cap: ₪150.0m
Does not have significant operations.
GFC-M
₪14.95
7D
0%
1Y
23.6%
Rekah Pharmaceutical Industry
Market Cap: ₪133.6m
Engages in the manufacture, marketing, sale, and distribution of pharmaceuticals, cosmetics, vitamins and nutritional supplements, and medical devices in Israel.
REKA
₪11.70
7D
-1.2%
1Y
-8.7%
Seach Medical Group
Market Cap: ₪104.2m
Manufactures and sells medicinal cannabis products worldwide.
SEMG
₪2.85
7D
-10.1%
1Y
8.2%
BioLineRx
Market Cap: ₪33.9m
A commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases.
BLRX
₪0.013
7D
-13.3%
1Y
-31.6%
BioLight Life Sciences
Market Cap: ₪25.2m
An ophthalmic company, engages in the discovery, development, and commercialization of products and product candidates that address ophthalmic conditions.
BOLT
₪2.78
7D
-18.0%
1Y
-58.4%
Evogene
Market Cap: ₪22.8m
Operates as a computational biology company in Israel, the United States, Israel, Brazil, and internationally.
EVGN
₪2.61
7D
-2.2%
1Y
-46.9%
Purple Biotech
Market Cap: ₪18.6m
A clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States.
PPBT
₪0.01
7D
0%
1Y
-80.8%
Can-Fite BioPharma
Market Cap: ₪13.5m
A clinical-stage biopharmaceutical company, develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction in Israel.
CANF
₪5.26
7D
-0.7%
1Y
-90.8%